Howe & Rusling’s ResMed RMD Stock Holding History

Howe & Rusling’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$275K	Buy	+1,410	New	+$292K	0.02%	267
2022 Q3	–	Sell	-5	Closed	-$1K	–	1174
2022 Q2	$1K	Buy	+5	New	+$1.06K	﹤0.01%	989

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Howe & Rusling's RMD Position: Q2 2026 in Review

Howe & Rusling opened a new position in ResMed (RMD) in Q2 2026: 1,410 shares worth $275K. The stake represents 0.02% of the portfolio and ranks #267 among its holdings. This is a return to the name: Howe & Rusling previously reported a position in RMD as recently as Q2 2022.

Howe & Rusling first reported a position in RMD in Q2 2022 and has held it in 2 quarters since. 890 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Howe & Rusling held 1,410 shares of ResMed worth $275K as of Q2 2026.
ResMed was a new Howe & Rusling position in Q2 2026.
ResMed made up 0.02% of Howe & Rusling's portfolio in Q2 2026, its #267 holding.
Howe & Rusling first reported a position in ResMed in Q2 2022 and has held it in 2 quarters since.
890 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Howe & Rusling's 13F filing for Q2 2026, filed 10 Aug 2026.